For patients on treatment at year @ , @ % maintained viral suppression ( HBV DNA < @ IU/mL ) , @ % achieved serum alanine aminotransferase normalization , and in HBeAg-positive patients , @/@ ( @ % ) and @/@ ( @ % ) achieved HBeAg and HBsAg loss , respectively .